Reaction
Retinal Neovascularisation reporting signals
As of the last recalculation, Retinal Neovascularisation appears in 247 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 240.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 58 | 240.3 | 240.8 |
| Aflibercept | 25 | 75.0 | 75.1 |
| Faricimab | 4 | 42.3 | 42.3 |